KANAMYCIN
Antibiotic (Aminoglycoside)
PREGNANCY RECOMMENDATION: Human Data Suggest Risk
BREASTFEEDING RECOMMENDATION: Limited Human Data—Probably Compatible
PREGNANCY SUMMARY
Except for ototoxicity, no reports of congenital defects due to kanamycin have been located. Embryos were examined from five patients who aborted during the 11th and 12th weeks of pregnancy and who had been treated with kanamycin during the 6th and 8th weeks (1). No abnormalities in the embryos were found.
FETAL RISK SUMMARY
Kanamycin is an aminoglycoside antibiotic. At term, the drug was detectable in cord serum 15 minutes after a 500-mg IM maternal dose (2
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
